You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 8,512,962


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,512,962
Title:Kit and method for detecting bovine viral diarrhea virus in tissue samples
Abstract: The present invention relates to the method for treatment of tissue samples with proteolytic/histolytic additive collagenase or other similar protease prior to testing with an antigen capture immunoassay to identify cattle infected with Bovine Viral Diarrhea Virus (BVDV). The use of collagenase or other similar protease in antigen extraction step of the assay drastically increases accuracy of the assay, thus it allows for a more effective, reliable, quick, and cost effective way of identifying and thereby removing infected cattle and/or other animals from an otherwise uninfected herd.
Inventor(s): Kostovic; Miladin (Brookfield, WI)
Assignee: Prionics AG (Schlieren, CH)
Application Number:12/745,877
Patent Claims:1. A kit for detecting BVDV antigens in a biological sample, the kit comprising: a solution comprising collagenase derived from Clostridium histolyticum capable of lysing cells in the biological sample to release and solubilize BVDV antigens; a primary antibody that binds to BVDV antigens; and a labeled antigen that binds to the primary antibody and/or a labeled antibody that binds to BVDV antigens.

2. The kit according to claim 1, wherein the primary antibody binds to non-structural BVDV protein NS2/3.

3. The kit according to claim 1, wherein the concentration of collagenase in the solution is from about 1 to about 20 mg/ml.

4. The kit according to claim 1, wherein the primary antibody is attached to a solid phase support.

5. The kit according to claim 1, wherein the labeled antigen and/or the labeled antibody includes a color-producing label.

6. The kit according to claim 1, wherein the labeled antigen and/or the labeled antibody includes an enzyme.

7. The kit according to claim 1, wherein the labeled antigen and/or the labeled antibody includes a fluorescent label.

8. A method for detecting BVDV antigens in a biological sample, the method comprising: contacting the biological sample with a solution comprising collagenase derived from Clostridium histolyticum capable of lysing cells in the biological sample to release and solubilize BVDV antigens; contacting the BVDV antigens released from the biological sample with a primary antibody that binds to BVDV antigens, and a labeled antibody for detecting the binding of the BVDV antigens to the primary antibody; and detecting the BVDV antigens bound to the primary antibody via the labeled antibody.

9. The method according to claim 8, wherein the primary antibody binds to non-structural BVDV protein NS2/3.

10. The method according to claim 8, wherein the concentration of collagenase in the solution is from about 1 to about 20 mg/ml.

11. The method according to claim 8, wherein the primary antibody is attached to a solid phase support.

12. The method according to claim 8, wherein the labeled antibody includes a color-producing label.

13. The method according to claim 8, wherein the labeled antibody includes an enzyme.

14. The method according to claim 8, wherein the labeled antibody includes a fluorescent label.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.